JERSEY CITY, N.J., Jan. 31, 2024 — WallachBeth Capital LLC, a leading provider of […]
Month: January 2024
Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development
TAIPEI, Jan. 31, 2024 — Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking […]
Nuvve Holding Corp. Announces Pricing of $9.6 Million Underwritten Public Offering
SAN DIEGO, Jan. 31, 2024 — Nuvve Holding Corp. (“Nuvve” or the “Company”) (Nasdaq: NVVE), […]
American Healthcare REIT to Host Webcast for Existing Stockholders
IRVINE, Calif., Jan. 30, 2024 — On January 29, 2024, American Healthcare REIT, Inc. (“AHR”) […]
Kodiak Gas Services Announces Pricing of $750 Million Senior Unsecured Notes Offering
MONTGOMERY, Texas, Jan. 30, 2024 — Kodiak Gas Services, Inc. (NYSE: KGS) (“Kodiak”, “we” […]
Thunder Energies Corporation Announces Major Strategic Initiatives for 2024 Following a Transformative Year
ATLANTA, Jan. 30, 2024 — Thunder Energies Corporation, a company at the forefront of […]
WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
JERSEY CITY, N.J., Jan. 30, 2024 — WallachBeth Capital LLC, a leading provider of […]
Cove Capital Investments, a Delaware Statutory Trust Sponsor Company Focused on Providing Debt Free DST Investments for 1031 Exchange Investors, Reports Expanded Capital Raise, New Investor Growth, and Significant Portfolio Expansion for 2023
Strong investor capital raise in 2023 helped propel Cove Capital Investments into one of the […]
Palatin Announces $10 Million Registered Direct Offering
CRANBURY, N.J., Jan. 30, 2024 — Palatin Technologies, Inc. (NYSE American: PTN) (“Palatin” or […]